DE68906854T2 - Dihydropyridinderivate. - Google Patents

Dihydropyridinderivate.

Info

Publication number
DE68906854T2
DE68906854T2 DE89402947T DE68906854T DE68906854T2 DE 68906854 T2 DE68906854 T2 DE 68906854T2 DE 89402947 T DE89402947 T DE 89402947T DE 68906854 T DE68906854 T DE 68906854T DE 68906854 T2 DE68906854 T2 DE 68906854T2
Authority
DE
Germany
Prior art keywords
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89402947T
Other languages
English (en)
Other versions
DE68906854D1 (en
Inventor
Choong Sup Kim
Jung Jin Suh
Bong Yong Lee
Chang Seop Kim
Jong Wook Lee
Byung Chae Kim
Byung Hee Han
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuhan Corp
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Application granted granted Critical
Publication of DE68906854D1 publication Critical patent/DE68906854D1/de
Publication of DE68906854T2 publication Critical patent/DE68906854T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE89402947T 1988-10-27 1989-10-25 Dihydropyridinderivate. Expired - Fee Related DE68906854T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019880014022A KR940003492B1 (ko) 1988-10-27 1988-10-27 1,4-디하이드로피리딘유도체 및 그의 제조방법

Publications (2)

Publication Number Publication Date
DE68906854D1 DE68906854D1 (en) 1993-07-08
DE68906854T2 true DE68906854T2 (de) 1994-01-13

Family

ID=19278797

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89402947T Expired - Fee Related DE68906854T2 (de) 1988-10-27 1989-10-25 Dihydropyridinderivate.

Country Status (5)

Country Link
US (1) US5089624A (de)
EP (1) EP0366548B1 (de)
JP (1) JPH0368555A (de)
KR (1) KR940003492B1 (de)
DE (1) DE68906854T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3286645B2 (ja) * 1993-03-26 2002-05-27 メルシャン株式会社 光学活性１，４−ジヒドロピリジン誘導体およびその製造方法
SE9303657D0 (sv) * 1993-11-05 1993-11-05 Astra Ab Short-acting dihydropyridines
PT657432E (pt) * 1993-12-10 2003-07-31 Bayer Ag 1,4-di-hidropiridinas fenil-substituidas com actividade cerebral

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
US4600778A (en) * 1983-04-05 1986-07-15 Bayer Aktiengesellschaft Process for the preparation of 1,4-dihydropyridinedicarboxylic esters
JPS6094963A (ja) * 1983-10-31 1985-05-28 Teijin Ltd １，４−ジヒドロピリジン−３，５−ジカルボン酸ジエステル誘導体及びその製造法

Also Published As

Publication number Publication date
JPH0565509B2 (de) 1993-09-17
EP0366548A1 (de) 1990-05-02
EP0366548B1 (de) 1993-06-02
KR900006292A (ko) 1990-05-07
US5089624A (en) 1992-02-18
JPH0368555A (ja) 1991-03-25
KR940003492B1 (ko) 1994-04-23
DE68906854D1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
DE122004000043I1 (de) Carbostryril-Derivate.
FI896014A0 (fi) Heterocykliska derivat.
ATE74125T1 (de) Didehydro-vitamin d3-derivate.
DE68925161D1 (de) Alkylavermectin-Derivate
DE68927948D1 (de) Trehalosderivate
DE58901056D1 (de) Dehydrocholecalciferolderivate.
ATE124397T1 (de) Piperidin-derivate.
DE68927657T2 (de) Butynylaminderivate
ATE124407T1 (de) Chromanderivate.
ATE126800T1 (de) Neplanocinderivate.
DK486089D0 (da) Pyranobenzoxadiazolderivater
ATE116985T1 (de) Chromanderivate.
DE68911192T2 (de) Phosphonoalkylpurin-Derivate.
DE58903265D1 (de) Fluorcyclopropyl-derivate.
DE68909873D1 (de) 1,4-Dihydropyridin-Derivate.
DK160389A (da) Aryldionderivater
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE68913856T2 (de) Cycloalkylthiazol-Derivate.
ATE109478T1 (de) Pyridin-derivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
ATA155589A (de) Mitomycinphosphat-derivate
DE68906854T2 (de) Dihydropyridinderivate.
NO892714D0 (no) Substituerte azacykloheksylderivater.
DE58900371D1 (de) 3-cyano-4-phenyl-pyrrol-derivate.
DK322489A (da) 1-normonylderivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee